ARCHIVE – IMIBIC-P²Med

HOME
ABOUT
- What is IMIBIC-P2Med?
- Programme Management
PROJECTS & FELLOWS
- GLIOCHEM
- HIDELIS
- MEMOIR
- ProsCanGO
- FluVac-Tregs
- Tac1-PCOS
NEWS
ARCHIVE
- Fellowships
- Call for proposals 2019
HELPDESK
IMIBIC-MIP 2021

ARCHIVE

Timetable
Application process
Eligibility
Evaluation process
Evaluation criteria
Application documents
Redress procedure
Frequently Asked Questions

IMIBIC-P²Med in Twitter

IMIBIC-P2MedFollow

IMIBIC Fellowship Programme for Personalised and Precision Medicine

Avatar IMIBIC-P2Med @IP2med·

This year 2022 the last MSCA fellow joined our IMIBIC-P2Med programme to start her research and training project @IMIBIC
We are now midway through the programme and we are looking forward to see the outcomes of our projects

Reply on Twitter 1607704179983646721 Retweet on Twitter 16077041799836467211 Like on Twitter 16077041799836467212 Twitter 1607704179983646721

Avatar IMIBIC-P2Med @IP2med·

New Open Access Research Article from our IMIBIC-P2Med fellow Marina Mora and members of the GC09 Nutrigenomics. Metabolic Syndrome group at
@IMIBIC

Reply on Twitter 1592456371294728192 Retweet on Twitter 15924563712947281924 Like on Twitter 15924563712947281927 Twitter 1592456371294728192

Avatar IMIBIC-P2Med @IP2med·

IMIBIC-P2Med programme featured in autumn 2022 issue of @EU_RESEARCH magazine. @IMIBIC we are pleased to have the opportunity to share information about our programme at EU Research

Reply on Twitter 1583424532832194562 Retweet on Twitter 15834245328321945621 Like on Twitter 15834245328321945623 Twitter 1583424532832194562

Retweet on Twitter IMIBIC-P2Med Retweeted

Avatar Maribel Martinez @maribeljer·

Un placer divulgar ciencia en los patios cordobeses #NightSpain @CordobaCiencia @IP2med @TeresaRoldanUCO @IMIBIC

Reply on Twitter 1576635198594510849 Retweet on Twitter 15766351985945108498 Like on Twitter 157663519859451084926 Twitter 1576635198594510849

Edificio IMIBIC
Avda Menéndez Pidal s/n
14004 Córdoba

+34 957 21 37 16
imibic.p2med@imibic.org

Terms of Use and Privacy